↓ Skip to main content

Dove Medical Press

Article Metrics

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
35 Mendeley
Title
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
Published in
Neuropsychiatric Disease and Treatment, October 2014
DOI 10.2147/ndt.s68297
Pubmed ID
Authors

Tariq Munshi, Usman Adam, Nusrat Husain, Peter Haddad, Fauzia Tariq, Farooq Naeem, Imran Chaudhry

Abstract

Tardive dyskinesia (TD) is a side effect of antipsychotic treatment that often only appears after months or years of treatment. A systematic review of randomized controlled trials lasting more than 1 year showed that second-generation antipsychotics (SGAs) were associated with an approximately fivefold lower risk of TD compared to haloperidol in patients with chronic schizophrenia. In contrast, there is little research on the risk of TD with other first-generation antipsychotics (FGAs), and this applies especially to their use in the treatment of patients with first episode psychosis (FEP).

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 20%
Researcher 5 14%
Student > Doctoral Student 5 14%
Other 5 14%
Student > Postgraduate 3 9%
Other 6 17%
Unknown 4 11%
Readers by discipline Count As %
Medicine and Dentistry 15 43%
Psychology 8 23%
Nursing and Health Professions 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Neuroscience 1 3%
Other 2 6%
Unknown 6 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2014.
All research outputs
#11,132,948
of 12,517,383 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,945
of 2,120 outputs
Outputs of similar age
#188,597
of 229,990 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#14
of 16 outputs
Altmetric has tracked 12,517,383 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,120 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,990 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.